Grifols (GIKLY) FCF Margin (2010 - 2019)
Grifols (GIKLY) reported FCF Margin of 9.08% for Q4 2019, up 162.59% quarter-over-quarter from 14.5% in Q1 2019.
Grifols (GIKLY) FCF Margin (2010 - 2019) Analysis & Trends
Grifols has reported FCF Margin for 9 years, with the latest figure at 9.08% in Q4 2019.
- For the quarter ending Q4 2019, FCF Margin changed N/A year-over-year to 9.08%; the trailing twelve-month figure through Dec 2019 stood at 8.12% (changed N/A YoY), and the FY2025 full-year result was 10.39%, down 26437.0% from the prior year.
- FCF Margin for Q4 2019 stood at 9.08%, up from 14.5% in the prior quarter.
- The five-year high for FCF Margin was 29.2% in Q4 2015, with the low at 14.5% in Q1 2019.
- Historically, FCF Margin has averaged 13.55% across 5 years, with a median of 16.43% in 2016.
- Annual changes were most pronounced in 2016 — FCF Margin surged 256 bps — and 2019, when it plunged 2356 bps.
- Grifols' FCF Margin stood at 29.2% in 2015, then sank by 44 bps to 16.43% in 2016, then grew by 26 bps to 20.62% in 2017, then plunged by 31 bps to 14.26% in 2018, then slumped by 36 bps to 9.08% in 2019.
- The last three FCF Margin figures came in at 9.08% (Q4 2019), 14.5% (Q1 2019), and 14.26% (Q2 2018), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Gsk | 93,699,046.73 Bn | 93,699,041.77 Bn | 7.76 Bn | 20.59% |
| 2 | Eli Lilly | 1,012.06 Bn | 1,006.77 Bn | 16.22 Bn | 15.19% |
| 3 | Johnson & Johnson | 560.67 Bn | 538.62 Bn | 15.96 Bn | 6.09% |
| 4 | AbbVie | 402.20 Bn | 392.85 Bn | 10.78 Bn | 23.76% |
| 5 | Merck | 298.59 Bn | 292.94 Bn | 12.09 Bn | 17.97% |
| 6 | Amgen | 188.77 Bn | 176.74 Bn | 5.87 Bn | 17.14% |
| 7 | Gilead Sciences | 160.22 Bn | 152.49 Bn | 5.52 Bn | 34.87% |
| 8 | Pfizer | 148.19 Bn | 135.42 Bn | -1.21 Bn | 93.16% |
| 9 | Bristol Myers Squibb | 116.72 Bn | 106.26 Bn | 8.07 Bn | 6.59% |
| 10 | Grifols | - | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2019 | 9.08% |
| Mar 31, 2019 | -14.50% |
| Jun 30, 2018 | 14.26% |
| Mar 31, 2018 | 9.06% |
| Jun 30, 2017 | 20.62% |
| Dec 31, 2016 | 16.43% |
| Sep 30, 2016 | 20.60% |
| Dec 31, 2015 | 29.20% |
| Sep 30, 2015 | 18.04% |
| Jun 30, 2015 | 22.48% |
| Mar 31, 2015 | 3.76% |
| Mar 31, 2013 | 13.51% |
| Dec 31, 2012 | 24.03% |
| Sep 30, 2012 | 20.79% |
| Jun 30, 2012 | 32.99% |
| Mar 31, 2012 | 0.01% |
| Dec 31, 2011 | 26.99% |
| Sep 30, 2011 | 7.76% |
| Jun 30, 2011 | -7.21% |
| Mar 31, 2011 | 16.69% |